Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89


Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer.

Wang W, Chen X, Li T, Li Y, Wang R, He D, Luo W, Li X, Wu X.

Exp Cell Res. 2013 May 1;319(8):1156-64. doi: 10.1016/j.yexcr.2013.02.007. Epub 2013 Mar 4.


A short peptide derived from the gN helix domain of FGF8b suppresses the growth of human prostate cancer cells.

Li T, Luo W, He D, Wang R, Huang Y, Zeng X, Wang W, Chen X, Gao S, Yu Y, Li X, Wu X.

Cancer Lett. 2013 Oct 10;339(2):226-36. doi: 10.1016/j.canlet.2013.06.001. Epub 2013 Jun 14.


Identification of a novel aFGF-binding peptide with anti-tumor effect on breast cancer from phage display library.

Dai X, Cai C, Xiao F, Xiong Y, Huang Y, Zhang Q, Xiang Q, Lou G, Lian M, Su Z, Zheng Q.

Biochem Biophys Res Commun. 2014 Mar 21;445(4):795-801. doi: 10.1016/j.bbrc.2014.02.022. Epub 2014 Feb 12.


A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.

Maruyama-Takahashi K, Shimada N, Imada T, Maekawa-Tokuda Y, Ishii T, Ouchi J, Kusaka H, Miyaji H, Akinaga S, Tanaka A, Shitara K.

Prostate. 2008 May 1;68(6):640-50. doi: 10.1002/pros.20728.


A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.

Giacomini A, Matarazzo S, Pagano K, Ragona L, Rezzola S, Corsini M, Di Salle E, Presta M, Ronca R.

Oncotarget. 2015 May 30;6(15):13790-802.


The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.

Song Z, Powell WC, Kasahara N, van Bokhoven A, Miller GJ, Roy-Burman P.

Cancer Res. 2000 Dec 1;60(23):6730-6.


Molecular cloning and characterization of human FGF8 alternative messenger RNA forms.

Ghosh AK, Shankar DB, Shackleford GM, Wu K, T'Ang A, Miller GJ, Zheng J, Roy-Burman P.

Cell Growth Differ. 1996 Oct;7(10):1425-34.


Screening a novel FGF3 antagonist peptide with anti-tumor effects on breast cancer from a phage display library.

Wang W, Chen T, Li H, Chen Y, Wu Z, Feng T, Zhang X, Zhong Q, Zhong Q, Li G, Guo L, Zhou L, Zhou J.

Mol Med Rep. 2015 Nov;12(5):7051-8. doi: 10.3892/mmr.2015.4248. Epub 2015 Aug 25.


Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.

Romanov VI, Durand DB, Petrenko VA.

Prostate. 2001 Jun 1;47(4):239-51.


Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).

Shen D, Xie F, Edwards WB.

PLoS One. 2013 Jul 25;8(7):e68339. doi: 10.1371/journal.pone.0068339. Print 2013.


[Molecular mechanism of FGF8b regulation of epithelial-mesenchymal transition in prostate cancer cells].

Fan B, Wang G, Qi F, Li Z, Liu H.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jul;37(7):656-61. doi: 10.3969/j.issn.1672-7347.2012.07.002. Chinese.


FGF8 isoform b expression in human prostate cancer.

Gnanapragasam VJ, Robinson MC, Marsh C, Robson CN, Hamdy FC, Leung HY.

Br J Cancer. 2003 May 6;88(9):1432-8.


Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.

Olsen SK, Li JY, Bromleigh C, Eliseenkova AV, Ibrahimi OA, Lao Z, Zhang F, Linhardt RJ, Joyner AL, Mohammadi M.

Genes Dev. 2006 Jan 15;20(2):185-98. Epub 2005 Dec 29.


Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.

Manohar SM, Padgaonkar AA, Jalota-Badhwar A, Rao SV, Joshi KS.

Prostate Cancer Prostatic Dis. 2012 Mar;15(1):15-27. doi: 10.1038/pcan.2011.51. Epub 2011 Nov 15.


Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.

Leali D, Alessi P, Coltrini D, Ronca R, Corsini M, Nardo G, Indraccolo S, Presta M.

Mol Cancer Ther. 2011 Sep;10(9):1600-10. doi: 10.1158/1535-7163.MCT-11-0286. Epub 2011 Jul 15.


A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library.

El-Mousawi M, Tchistiakova L, Yurchenko L, Pietrzynski G, Moreno M, Stanimirovic D, Ahmad D, Alakhov V.

J Biol Chem. 2003 Nov 21;278(47):46681-91. Epub 2003 Sep 2.


High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.

Iljin K, Ketola K, Vainio P, Halonen P, Kohonen P, Fey V, Grafström RC, Perälä M, Kallioniemi O.

Clin Cancer Res. 2009 Oct 1;15(19):6070-8. doi: 10.1158/1078-0432.CCR-09-1035. Epub 2009 Sep 29.


Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.

Piossek C, Schneider-Mergener J, Schirner M, Vakalopoulou E, Germeroth L, Thierauch KH.

J Biol Chem. 1999 Feb 26;274(9):5612-9.


Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.

Larbanoix L, Burtea C, Ansciaux E, Laurent S, Mahieu I, Vander Elst L, Muller RN.

Peptides. 2011 Jun;32(6):1232-43. doi: 10.1016/j.peptides.2011.04.026. Epub 2011 May 6.


Supplemental Content

Support Center